141 related articles for article (PubMed ID: 6175933)
61. Rapidly alternating chemotherapy and hyperfractionated radiotherapy in the management of locally advanced head and neck carcinoma: four-year results of a phase I/II study.
Leyvraz S; Pasche P; Bauer J; Bernasconi S; Monnier P
J Clin Oncol; 1994 Sep; 12(9):1876-85. PubMed ID: 8083711
[TBL] [Abstract][Full Text] [Related]
62. Single agents known to be active in head and neck cancer.
Monfardini S; Volonterio A; Marchini S
Chemioterapia; 1985 Aug; 4(4):303-9. PubMed ID: 2414016
[TBL] [Abstract][Full Text] [Related]
63. Sequential combination chemotherapy of advanced head and neck carcinoma: re-evaluation of a highly effective regimen.
Veronesi A; Barzan L; Magri MD; Tirelli U; Galligioni E; Trovò MG; Tumolo S; Comoretto R; Grigoletto E
Strahlentherapie; 1981 Apr; 157(4):277-9. PubMed ID: 6166105
[TBL] [Abstract][Full Text] [Related]
64. [The remission of extensive cancers of the mouth and oropharynx with intra-arterial polychemotherapy with vincristine, methotrexate, bleomycin, cisplatin (VMBP)].
Mika H
Laryngol Rhinol Otol (Stuttg); 1982 Sep; 61(9):520-3. PubMed ID: 6183545
[TBL] [Abstract][Full Text] [Related]
65. A phase II trial of a new combination chemotherapy (cisplatin, bleomycin, VP-16 and methylprednisolone) in advanced recurrent squamous cell carcinoma of the head and neck.
Senra Varela A; Millan Nuñez-Cortes J; Gallurt Moreira P
Oncology; 1988; 45(6):458-60. PubMed ID: 3186156
[TBL] [Abstract][Full Text] [Related]
66. Synchronous multiple drug chemotherapy and radiotherapy for advanced (stage III and IV) squamous carcinoma of the head and neck.
Clifford P; O'Connor AD; Durden-Smith J; Hollis BA; Edwards WG; Dalley VM
Antibiot Chemother (1971); 1978; 24():60-72. PubMed ID: 77659
[No Abstract] [Full Text] [Related]
67. Comparison of methotrexate and cisplatin for patients with advanced squamous cell carcinoma of the head and neck region: a Southwest Oncology Group Study.
Grose WE; Lehane DE; Dixon DO; Fletcher WS; Stuckey WJ
Cancer Treat Rep; 1985 Jun; 69(6):577-81. PubMed ID: 4040421
[TBL] [Abstract][Full Text] [Related]
68. Treatment of advanced squamous cell carcinoma of the head and neck with cisplatin, bleomycin, and methotrexate (PBM).
Ervin TJ; Weichselbaum R; Miller D; Meshad M; Posner M; Fabian R
Cancer Treat Rep; 1981; 65(9-10):787-91. PubMed ID: 6168371
[TBL] [Abstract][Full Text] [Related]
69. Chemotherapy of squamous cell cancer of the head and neck.
Gill PG; Hains JD; Iyer P; Rozenbilds JG; Ahmad A; Abbott RL; David DJ; Ward GG; Brown MW; Harvey ND
Med J Aust; 1983 May; 1(10):463-6. PubMed ID: 6188946
[TBL] [Abstract][Full Text] [Related]
70. Phase II trial of vindesine in advanced squamous cell cancer of the head and neck.
Vogl SE; Camacho FJ; Kaplan BH; O'Donnell MR
Cancer Treat Rep; 1984 Mar; 68(3):559-60. PubMed ID: 6704987
[No Abstract] [Full Text] [Related]
71. Methotrexate-vindesine association in the treatment of head and neck cancer influence of vindesine on methotrexate's pharmacokinetic behavior.
Lena N; Imbert AM; Pignon T; Favre R; Meyer G; Cano JP; Carcassonne Y
Cancer Chemother Pharmacol; 1984; 12(2):120-4. PubMed ID: 6697425
[TBL] [Abstract][Full Text] [Related]
72. The chemotherapy of head and neck cancer.
Carter SK
Semin Oncol; 1977 Dec; 4(4):413-24. PubMed ID: 74095
[No Abstract] [Full Text] [Related]
73. Serum glycoproteins in head and neck squamous carcinoma: correlations with tumor extent, clinical tumor stage, and T-cell levels during chemotherapy.
Wolf GT; Chretien PB; Elias EG; Makuch RW; Baskies AM; Spiegel HE; Weiss JF
Am J Surg; 1979 Oct; 138(4):489-500. PubMed ID: 90464
[No Abstract] [Full Text] [Related]
74. A trial of outpatient chemotherapy for recurrent head and neck tumors.
Huang AT; Lucas VS; Baughn SG; Cole TB
Cancer; 1980 Apr; 45(8):2038-41. PubMed ID: 6154522
[TBL] [Abstract][Full Text] [Related]
75. Chemotherapy of head and neck cancer.
Green MR
Head Neck Surg; 1978; 1(1):75-86. PubMed ID: 91591
[TBL] [Abstract][Full Text] [Related]
76. Combination therapy of advanced head and neck cancer: induction of remissions with diamminedichloroplatinum (II), bleomycin and radiation therapy.
Randolph VL; Vallejo A; Spiro RH; Shah J; Strong EW; Huvos AG; Wittes RE
Cancer; 1978 Feb; 41(2):460-7. PubMed ID: 75760
[TBL] [Abstract][Full Text] [Related]
77. A randomized prospective study of vindesine versus doxorubicin and cyclophosphamide in the treatment of epidermoid lung cancer.
Luedke DW; Luedke SL; Petruska P; Broun GO; Leavitt J; Schlueter J
Cancer; 1983 Mar; 51(5):778-82. PubMed ID: 6336984
[TBL] [Abstract][Full Text] [Related]
78. Regional chemotherapy with combined drugs in cancer of the head and neck.
Donegan WL; Harris P
Cancer; 1976 Oct; 38(4):1479-83. PubMed ID: 62604
[TBL] [Abstract][Full Text] [Related]
79. Chemotherapy of human head and neck cancer xenografts with three clinically active drugs: cis-platinum, bleomycin and methotrexate.
Braakhuis BJ; Schoevers EJ; Heinerman EC; Sneeuwloper G; Snow GB
Br J Cancer; 1983 Nov; 48(5):711-6. PubMed ID: 6196043
[TBL] [Abstract][Full Text] [Related]
80. Bleomycin in advanced squamous cell carcinoma: a random controlled trial. Report of Medical Research Council Working Party on Bleomycin.
Br Med J; 1976 Jan; 1(6003):188-90. PubMed ID: 55288
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
